Grant enhances mental illness drug research efforts

La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

Findings reveal new target in quest to ease schizophrenia